SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GenVec - GNVC
GNVC 7.1930.0%Jun 26 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Gary Mohilner4/9/2010 1:18:01 AM
   of 106
 
The following link is an article on OPXA, I've provided the link because they like GNVC have dealings with Novartis.

realtimetraders.com

Please note they sold their entire stem cell technology for a fraction of what GNVC got for a single drug that Novartis partnered with GNVC. Look at the milestones, over $200 million for GNVC, $50M for OPXA.

I believe any comparison shows how much more highly Novartis viewed GNVC's drug, but it also may indicate something about GNVC negotiating skills compared to others.

Gary
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext